OakChart

Xtant Medical Holdings Inc

XTNTHealthcare·Medical Devices·USA·Nano·AMEX·Nov 11 • 3:25 PM ET

0.2750+0.0001 (0.04%)
2026-11-11 22:07 CET
Market cap
38.57 USD m
Revenue, TTM
109.53 USD m
Net income, TTM
-11.14 USD m
Free cash flow, TTM
-0.70 USD m
EPS diluted, TTM
-0.08
P/E
-
Compare

Price

XTNT against its 20, 50 and 200-day averages
2050200missearnings
0.300.400.500.6038.8M77.6MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26XTNTclose 0.2820-day 0.2950-day 0.32200-day 0.450.28

67.3% under the 52-week high of 0.84 on 18 Dec 2025. 52-week low 0.27 on 12 Aug 2026. Last 15 sessions, 20.9% high to low

Volume 0.12× normal · the line is the 50-bar volume average

Profile

XTNT
52-week range, 1% of the way up
0.270.84

Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoSTX, Certex Spinal Fixation System, Axle Interspinous Fusion System, and Calix. The company was founded in 2006 and is headquartered in Belgrade, MT.

Employees151
IPOJul 01, 2010
Beta-0.25
ATR, 14d0.02
Rel volume0.12
Short float0.31%
Insider own12.43%
Inst own57.10%

Snapshot

6 groups

Valuation

Index-
Market Cap38.58M
Enterprise Value54.37M
Income-11.14M
Sales109.53M
Book/sh0.29
Cash/sh0.07
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees151
IPOJul 01, 2010

Ratios

P/E-
Forward P/E-
PEG-
P/S0.35
P/B0.96
P/C3.78
P/FCF-
EV/EBITDA-
EV/Sales0.50
Quick Ratio1.05
Current Ratio2.16
Debt/Eq0.65
LT Debt/Eq0.24
Option/ShortNo / Yes

Earnings

EPS (ttm)-0.08
EPS next Y-0.01
EPS next Q-0.03
EPS this Y-183.33%
EPS next Y60.00%
EPS next 5Y-
EPS past 3/5Y- -
Sales past 3/5Y32.20% 20.22%
EPS Y/Y TTM-132.84%
Sales Y/Y TTM-14.27%
EPS Q/Q-380.75%
Sales Q/Q-34.96%
EarningsNov 16 BMO
EPS/Sales Surpr.-250.00% -7.41%

Ownership

Insider Own12.43%
Insider Trans0.00%
Inst Own57.10%
Inst Trans-0.62%
ROA-12.16%
ROE-25.16%
ROIC-22.41%
Gross Margin59.39%
Oper. Margin-9.58%
Profit Margin-10.17%
SMA20-4.46%
SMA50-14.77%
SMA200-38.48%
Trades-

Technical

Shs Outstand140.26M
Shs Float122.86M
Short Float0.31%
Short Ratio0.22
Short Interest0.38M
52W High0.84 -67.26%
52W Low0.27 1.78%
Volatility10.65% 8.41%
ATR (14)0.02
RSI (14)38.75
Beta-0.25
Rel Volume0.12
Avg Volume1.69M
Volume202,429

Performance

Perf Week-7.09%
Perf Month-15.20%
Perf Quarter-11.86%
Perf Half Y-42.71%
Perf YTD-64.92%
Perf Year-63.64%
Perf 3Y-76.50%
Perf 5Y-75.23%
Perf 10Y-96.13%
Recom1.00
Target Price1.03
Prev Close0.27
Price0.28
Change %0.04%

Analyst ratings

latest 3 of 3
DateActionAnalystRating changeTargetImplied
Dec 05, 2023InitiatedBBTIG ResearchBuy$2+627.3%
Nov 15, 2018ReiteratedMMaxim GroupBuy$10 → $6+2,081.8%
Feb 14, 2018ReiteratedMMaxim GroupBuy$18 → $10+3,536.4%

Peers

Mkt cap
TickerCompanyMkt cap
OFIXOrthofix Medical Inc292.66M
ATECAlphatec Holdings Inc1.14B
SIBNSI-BONE Inc1.13B
BVSBioventus Inc926.03M
SINTSINTX Technologies Inc12.25M
ELUTElutia Inc40.75M
TNONTenon Medical Inc4.69M
GMEDGlobus Medical Inc9.98B
CARLCarlsmed Inc507.83M
MDXGMimedx Group Inc484.47M

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
BUSMEA Bridgeway Ultra-Small Company Market ETFAUM: 111.21M

News

latest 14 of 196

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-16--0.025--25.482
2026Q22026-08-11-0.070-0.020-0.07023.0324.881
2026Q12026-05-13-0.020-0.015-0.02220.8820.162
2025Q42026-03-310.000-0.0050.00032.3630.752
2025Q32025-11-100.009-0.0050.00933.2632.692
2025Q22025-08-12-0.094-0.0120.02435.4131.362
2025Q12025-05-120.279-0.0080.00032.9031.222
2024Q42025-03-06-0.020-0.014-0.02331.5131.802
2024Q32024-11-12-0.040-0.025-0.03727.9429.302
2024Q22024-08-08-0.030-0.021-0.03029.9428.702
2024Q12024-05-15-0.030-0.016-0.03427.8725.772
2023Q42024-04-01-0.030-0.025-0.03328.1126.542
2023Q32023-11-090.070-0.0100.06825.0218.901
2023Q22023-08-01-0.020-0.020-0.02020.2319.501
2023Q12023-05-04-0.020-0.030-0.01917.9415.201
2022Q42023-03-07-0.020--0.02015.30--

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2017FY-34.760-10.770-34.76182.6183.29
2018FY-1.500--5.97172.2071.44
2019FY-0.590-0.720-0.62564.6865.07
2020FY-0.250--0.24653.34-
2021FY-0.060--0.05755.26-
2022FY-0.090--0.09058.00-
2023FY0.010-0.0320.00591.3089.74
2024FY-0.120-0.114-0.123117.27117.52
2025FY0.0300.0270.033133.93132.29
2026FY--0.025--99.44
2027FY--0.010--110.24
2028FY--0.020--118.84

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-10-2530025.4823.9026.60
2026Q3S2026-09-0130225.4823.9026.60
2026Q3S2026-08-1120226.2725.9426.60
2026Q3S2026-07-2720027.0926.9827.20
2026Q3S2026-07-0922027.0926.9827.20
2026Q3S2026-06-0933027.3526.9827.88
2026Q3S2026-05-1433027.3626.9827.90
2026Q3S2026-05-1333027.3626.9827.90
2026Q3S2026-04-2332025.3423.8126.90
2026Q3S2026-04-1731123.8922.5625.30
2026Q3S2026-04-1021123.9322.5625.30
2026Q3S2026-03-3121124.0022.7025.30
2026Q3S2026-03-1720126.0622.5029.62
2026Q3S2026-01-2520026.7123.8029.62

Estimate history

EPS, annual-34.761-5.971-0.625-0.246-0.057-0.090.005-0.1230.033-0.0801
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.03-0.037-0.02300.0240.0090-0.022-0.067
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual82.61272.20364.68253.33755.26357.96991.303117.267133.927109.53
Period201720182019202020212022202320242025TTM
Sales, quarterly29.94327.93731.51332.90435.41133.25532.35720.88423.031
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual1.51513.17213.16277.57487.069108.875130.18139.046140.04140.263
Period201720182019202020212022202320242025MRQ
Shares, quarterly130.314138.681139.046139.082139.316140.004140.04140.068140.263
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue109.53133.93117.2791.3057.9755.2653.3464.6872.20
Cost of Goods Sold Incl. D&A44.4849.6549.0535.8425.8322.7718.9522.2232.84
Gross Profit65.0584.2768.2255.4732.1432.4934.3942.4639.37
Selling, General and Administrative Excl. Other75.5476.9980.2965.6238.8936.3435.1444.7146.76
Research and Development2.222.102.381.340.920.870.660.931.70
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-10.497.28-12.07-10.16-6.75-3.85-0.75-2.25-7.39
Interest Expense2.763.674.162.941.690.995.985.7710.14
Unusual Expense0.000.000.000.000.000.000.00-0.0052.56
Net Income Before Taxes-9.247.00-16.26-1.04-8.42-4.85-6.73-8.12-70.10
Income Taxes1.902.030.19-1.700.070.000.300.100.00
Consolidated Net Income-11.144.97-16.450.66-8.48-4.85-7.02-8.22-70.10
Net Income From Continuing Operations-11.144.97-16.450.66-8.48-4.85-7.02-8.22-70.10
Net Income-11.144.97-16.450.66-8.48-4.85-7.02-8.22-70.10
EPS (Recurring)-0.080.03-0.120.01-0.09-0.06-0.25-0.62-2.84
EPS (Basic, Before Extraordinaries)-0.080.04-0.120.01-0.09-0.06-0.25-0.62-5.97
EPS (Diluted)-0.080.03-0.120.01-0.09-0.06-0.25-0.62-5.97
EBITDA-6.4712.51-7.85-6.98-5.46-2.511.340.95-1.66
Non-Operating Income (Expense)4.023.39-0.0312.060.030.000.00-0.100.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.362.283.252.161.951.610.790.380.81
Price To Earnings Ratio---132.94-----
Price To Sales Ratio0.540.880.501.571.070.870.640.330.26
Gross Margin59.3962.9258.1760.7555.4458.7964.4865.6454.52
Operating Margin-9.585.44-10.30-11.13-11.65-6.97-1.41-3.48-10.24
Net Margin-10.173.71-14.030.72-14.64-8.77-13.17-12.71-97.09
Shares Outstanding140.26140.04139.05130.18108.8787.0777.5713.1613.17
Market Capitalization38.5738.5761.58147.0271.7148.6192.7921.0621.21

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue23.0320.8832.3633.2635.4132.9031.5127.94
Cost of Goods Sold Incl. D&A9.708.9114.6011.2611.1312.6615.4911.63
Gross Profit13.3311.9717.7521.9924.2820.2416.0216.31
Selling, General and Administrative Excl. Other22.5014.8918.7019.4519.6619.1817.9120.08
Research and Development0.690.430.460.630.570.440.520.70
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-9.17-2.92-0.942.544.621.06-1.88-3.78
Interest Expense0.540.600.720.901.001.041.131.20
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-9.34-3.061.601.563.810.03-3.14-4.96
Income Taxes0.070.031.540.260.26-0.030.020.06
Consolidated Net Income-9.41-3.090.061.313.550.06-3.17-5.02
Net Income From Continuing Operations-9.41-3.090.061.313.550.06-3.17-5.02
Net Income-9.41-3.090.061.313.550.06-3.17-5.02
EPS (Recurring)-0.07-0.020.000.010.020.00-0.02-0.04
EPS (Basic, Before Extraordinaries)-0.07-0.020.000.010.030.00-0.02-0.04
EPS (Diluted)-0.07-0.020.000.010.020.00-0.02-0.04
EBITDA-8.66-2.390.883.705.792.14-0.73-2.70
Non-Operating Income (Expense)0.370.463.26-0.070.180.01-0.130.01
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.690.590.570.510.610.601.560.90
Price To Earnings Ratio-51.1976.86-----
Price To Sales Ratio0.540.640.880.730.860.550.530.80
Gross Margin57.8857.3254.8766.1368.5861.5250.8558.37
Operating Margin-39.81-14.00-2.927.6413.063.23-5.97-13.52
Net Margin-40.87-14.790.183.9310.030.18-10.04-17.98
Shares Outstanding140.26140.07140.04140.00139.32139.08139.05138.68
Market Capitalization38.5778.12109.7684.56102.9665.3661.5893.77

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments17.336.225.9220.5118.392.345.246.802.86
Short Term Receivables28.2720.6620.7310.857.156.8810.129.9912.71
Inventories30.2638.6336.8817.2917.9521.4116.1017.3022.23
Other Current Assets2.391.601.330.670.840.740.780.591.71
Total Current Assets78.2567.1264.8749.3244.3331.3632.2534.6839.50
Net Property, Plant & Equipment9.3910.9610.217.176.476.046.797.179.91
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets6.3715.6617.393.553.603.663.723.7855.36
Other Assets0.130.100.140.200.290.400.390.790.93
Total Assets94.1493.8492.6160.2354.6941.4743.1646.42105.70
Short Term Debt Incl. Current Port. of LT Debt15.0112.895.526.234.1117.240.570.430.37
Accounts Payable3.847.927.053.492.622.292.196.469.48
Income Tax Payable2.18--------
Other Current Liabilities8.447.7710.425.504.356.126.635.1615.98
Total Current Liabilities29.4828.5822.9915.2211.0825.659.3912.0525.82
Long Term Debt13.7022.2518.0410.8412.731.3074.6950.97127.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities0.010.040.02------
Other Liabilities0.000.000.210.000.000.003.2827.1811.58
Total Liabilities43.1950.8741.2626.0623.8126.9587.3690.19164.40
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity50.9542.9651.3534.1730.8814.51-44.20-43.77-58.70
Total Shareholders Equity50.9542.9651.3534.1730.8814.51-44.20-43.77-58.70
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity50.9542.9651.3534.1730.8814.51-44.20-43.77-58.70
Total Liabilities & Stockholders Equity94.1493.8492.6160.2354.6941.4743.1646.42105.70
Book Value Per Share0.360.310.390.310.350.19-3.36-3.32-38.75
Tangible Book Value Per Share0.320.200.260.280.310.14-3.64-3.61-75.29
Full-Time Employees151232215135118110141166174
Price to Book Ratio0.961.342.682.051.49-0.33-0.49-0.48-0.34
Return on Assets5.29-17.640.86-14.77-10.09-16.60-18.36-92.16-41.96
Return on Equity10.59-34.881.54-26.09-21.36----
Return on Invested Capital7.69-25.220.95-18.85-11.12-44.40-26.97-974.54-76.73
Quick Ratio1.631.001.222.102.380.391.721.440.67
Current Ratio2.652.352.823.244.001.223.432.881.53

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-11.144.97-16.450.66-8.48-4.85-7.02-8.22-70.10
Depreciation4.025.224.223.171.301.342.103.146.59
Other Funds (Non Cash)11.545.355.68-9.714.663.157.477.2263.79
Funds from Operations4.4215.54-6.55-5.88-2.53-0.352.542.140.28
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-3.85-3.05-5.35-3.63-2.810.79-3.27-2.550.93
Cash from Operating Activities0.5712.50-11.90-9.52-5.340.44-0.73-0.411.21
Capital Expenditures-1.27-2.38-4.11-1.46-1.76-2.12-1.54-0.88-0.62
Net Assets From Acquisitions0.000.000.00-23.500.000.000.000.00-
Sale of Fixed Assets and Businesses20.6510.280.380.170.200.230.240.340.26
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses-5.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities14.397.90-3.73-24.78-1.56-1.89-1.30-0.54-0.37
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-0.07-0.074.4714.019.3118.430.670.006.81
Repurchase of Common Pref Stock-0.07-0.070.000.000.000.000.000.000.00
Sale of Common Pref Stock0.000.004.4714.019.3118.430.670.006.81
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.006.81
Issuance or Reduction of Debt, Net-11.84-9.3311.785.94-0.29-0.59-0.47-0.60-0.36
Change in Long Term Debt-11.82-8.074.284.70-0.05-0.46-0.47-0.60-0.36
Issuance of Long Term Debt0.000.004.354.760.000.000.000.000.00
Reduction of Long Term Debt-11.82-8.07-0.07-0.06-0.05-0.46-0.47-0.60-0.36
Net Financing Active Other Cash Flow-0.12-0.13-0.18-0.260.00-0.34-1.060.00-3.36
Other Financing Activities Uses-0.12-0.13-0.18-0.260.00-0.34-1.060.00-3.36
Cash from Financing Activities-12.03-9.5216.0719.699.0217.50-0.86-0.603.10
Exchange Rate Effect0.250.23-0.150.02-----
Net Change in Cash3.1811.110.30-14.582.1216.05-2.90-1.563.94
Free Cash Flow-0.7010.12-16.01-10.97-7.11-1.68-2.28-1.290.59
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow-11.63------32.15
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments10.2212.1617.3310.647.045.43
Short Term Receivables19.4217.1828.2725.5226.9523.48
Inventories33.2931.8830.2640.7140.1338.81
Other Current Assets1.861.402.391.461.471.42
Total Current Assets64.7862.6278.2578.3375.5969.14
Net Property, Plant & Equipment8.448.909.3913.6313.0811.46
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets6.336.356.3714.3614.7915.23
Other Assets0.130.130.130.000.010.00
Total Assets79.6778.0094.14106.32103.4895.83
Short Term Debt Incl. Current Port. of LT Debt16.334.8115.0112.1112.7511.97
Accounts Payable6.155.493.846.867.227.12
Income Tax Payable0.091.832.18---
Other Current Liabilities7.396.648.4416.5410.6310.49
Total Current Liabilities29.9618.7729.4835.5030.6029.58
Long Term Debt9.6810.6213.7020.3824.3222.33
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities--0.01---
Other Liabilities0.010.010.000.060.050.05
Total Liabilities39.6529.4043.1955.9454.9851.96
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity40.0248.6050.9550.3848.5043.88
Total Shareholders Equity40.0248.6050.9550.3848.5043.88
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity40.0248.6050.9550.3848.5043.88
Total Liabilities & Stockholders Equity79.6778.0094.14106.32103.4895.83
Book Value Per Share0.290.350.360.360.350.32
Tangible Book Value Per Share0.240.300.320.260.240.21
Full-Time Employees--151---
Price to Book Ratio0.961.612.181.862.341.52
Return on Assets-12.162.105.291.71-4.60-12.64
Return on Equity-25.163.9510.593.64-9.80-26.20
Return on Invested Capital-18.94-5.220.091.854.870.09
Quick Ratio1.051.641.631.061.161.03
Current Ratio2.163.342.652.212.472.34

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-9.41-3.090.061.313.550.06
Depreciation0.510.531.821.161.171.07
Other Funds (Non Cash)6.871.970.881.821.011.63
Funds from Operations-2.03-0.592.754.295.732.76
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-5.28-1.522.630.32-4.47-1.52
Cash from Operating Activities-7.31-2.115.384.611.261.24
Capital Expenditures-0.25-0.19-0.40-0.43-0.37-1.19
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.0610.4110.070.110.050.05
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses-5.000.000.000.000.000.00
Other Sources0.000.00-5.005.000.000.00
Cash from Investing Activities-5.1910.224.684.68-0.32-1.14
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.00-0.070.000.000.00
Repurchase of Common Pref Stock0.000.00-0.070.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net10.60-13.27-3.47-5.720.73-0.88
Change in Long Term Debt-0.94-2.85-3.02-5.02-0.02-0.02
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt-0.94-2.85-3.02-5.02-0.02-0.02
Net Financing Active Other Cash Flow-0.05-0.01-0.01-0.06-0.05-0.01
Other Financing Activities Uses-0.05-0.01-0.01-0.06-0.05-0.01
Cash from Financing Activities10.56-13.28-3.54-5.770.68-0.89
Exchange Rate Effect0.00-0.000.170.08-0.02-0.00
Net Change in Cash-1.94-5.176.693.601.60-0.79
Free Cash Flow-7.55-2.314.994.180.900.05
Price to Free Cash Flow-10.0811.6619.05--

Revenue breakdown

License2024: 1.50M 2025: 18.72M
Product2024: 115.77M 2025: 115.20M
Non-US2024: 11.75M 2025: 11.48M
United States2024: 105.52M 2025: 122.45M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.31%0.4M122.9M1.67M
2026-10-150.24%0.3M122.9M1.66M
2026-09-300.12%0.1M122.9M1.69M
2026-09-150.22%0.3M122.9M1.69M
2026-08-311.49%1.8M122.9M1.48M
2026-08-140.08%0.1M122.9M125.00K
2026-07-310.07%0.1M120.9M113.88K
2026-07-150.06%0.1M120.9M125.85K
2026-06-300.00%0.0M120.9M140.57K
2026-06-150.00%0.0M117.9M157.25K
2026-05-290.00%0.0M117.8M160.31K
2026-05-150.02%0.0M117.8M145.52K
2026-04-300.06%0.1M117.7M147.89K
2026-04-150.01%0.0M117.7M163.14K
2026-03-310.03%0.0M117.7M156.59K
2026-03-130.02%0.0M117.6M175.86K
2026-02-270.02%0.0M117.6M186.23K
2026-02-130.02%0.0M117.6M195.84K
2026-01-300.02%0.0M115.8M241.90K
2026-01-150.02%0.0M115.8M272.15K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-118-KCurrent report2026-08-11SEC
2026-08-078-KCurrent report2026-08-07SEC
2026-06-23ARSAnnual report to security holders. 2025-12-31SEC
2026-06-23DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-06-23DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-23SEC
2026-05-29SDSpecialized Disclosure ReportSEC
2026-05-13S-8 POSPost-effective amendment to a S-8 registration statementSEC
2026-05-13S-8 POSPost-effective amendment to a S-8 registration statementSEC
2026-05-13S-8 POSPost-effective amendment to a S-8 registration statementSEC
2026-05-13S-8 POSPost-effective amendment to a S-8 registration statementSEC
2026-05-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-138-KCurrent report2026-05-13SEC
2026-04-138-KCurrent report2026-04-10SEC
2026-03-3110-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-03-318-KCurrent report2026-03-31SEC
2026-03-028-KCurrent report2026-03-02SEC
2026-02-184Statement of changes in beneficial ownership of securities2026-02-15SEC
2026-02-17SCHEDULE 13G/ASEC
2026-01-164Statement of changes in beneficial ownership of securities2026-01-15SEC
2026-01-168-KCurrent report2026-01-15SEC
2025-12-038-KCurrent report2025-12-01SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Nantahala Capital Management, LLC97.52%
AWM Investment Company, Inc.4.26%
VANGUARD CAPITAL MANAGEMENT LLC1.44%
RENAISSANCE TECHNOLOGIES LLC0.67%
GEODE CAPITAL MANAGEMENT, LLC0.37%
Crescent Grove Advisors, LLC0.29%
NANO CAP NEW MILLENNIUM GROWTH FUND L P0.29%
VANGUARD FIDUCIARY TRUST CO0.18%
CITADEL ADVISORS LLC0.14%
ACADIAN ASSET MANAGEMENT LLC0.13%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND1.07%
VANGUARD EXTENDED MARKET INDEX FUND0.37%
Fidelity Extended Market Index Fund0.16%
Ultra-Small Company Market Fund0.11%
Fidelity Total Market Index Fund0.08%
Fidelity Series Total Market Index Fund0.05%

OakChart. XTNT. Cached 15 minutes.

Some panels did not load: insider.